长效甲状腺刺激素与甲状腺微粒体抗体之间的关系。 - Suppr | 超能文献

Relationship between the long-acting thyroid stimulator and the thyroid microsomal antibody.

作者信息

Bonnyns M, Vanhaelst L

出版信息

J Endocrinol. 1969 Jan;43(1):125-6. doi: 10.1677/joe.0.0430125.

DOI:10.1677/joe.0.0430125

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Relationship between the long-acting thyroid stimulator and the thyroid microsomal antibody.长效甲状腺刺激素与甲状腺微粒体抗体之间的关系。

J Endocrinol. 1969 Jan;43(1):125-6. doi: 10.1677/joe.0.0430125.

2

Heterogeneity of long acting thyroid stimulating (LATS)-activity, thyroglobulin antibodies and thyroid microsomal antibodies.长效甲状腺刺激素（LATS）活性、甲状腺球蛋白抗体及甲状腺微粒体抗体的异质性。

Acta Endocrinol (Copenh). 1973 Jul;73(3):483-8. doi: 10.1530/acta.0.0730483.

3

Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies.

J Clin Endocrinol Metab. 1970 Aug;31(2):119-33. doi: 10.1210/jcem-31-2-119.

4

Relationship between the long-acting thyroid stimulator and circulating thyroid antibodies in Graves' disease.格雷夫斯病中长效甲状腺刺激素与循环甲状腺抗体之间的关系。

J Clin Endocrinol Metab. 1967 Dec;27(12):1758-60. doi: 10.1210/jcem-27-12-1758.

5

The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).长效甲状腺刺激素（LATS）水平高的格雷夫斯病患者甲状腺放射性消融的效果。

Am J Med. 1969 Feb;46(2):217-26. doi: 10.1016/0002-9343(69)90006-0.

6

Hypothyroidism after treatment with sodium iodide I-131. Incidence and relationship to antithyroid antibodies, long-acting thyroid stimulator (LATS), and infiltrative ophthalmopathy.

JAMA. 1969 Nov 10;210(6):1051-8. doi: 10.1001/jama.210.6.1051.

7

Thyroid-stimulating immunoglobulins in Graves' disease.格雷夫斯病中的促甲状腺素受体抗体

Lancet. 1974 Aug 24;2(7878):427-31. doi: 10.1016/s0140-6736(74)91815-7.

8

[Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].[关于甲状腺功能亢进症中甲状腺抗体与长效甲状腺刺激素之间关系问题的研究]

Med Klin. 1966 Dec 30;61(52):2062-3.

9

Neonatal transient thyrotoxicosis resulting from maternal TSH-binding inhibitor immunoglobulins.母体促甲状腺素结合抑制性免疫球蛋白导致的新生儿暂时性甲状腺毒症。

J Pediatr. 1983 Oct;103(4):591-3. doi: 10.1016/s0022-3476(83)80594-0.

10

[Simultaneous study of LATS and antimicrosomial antibodies in untreated Basedow's disease].

Presse Med (1893). 1971 May 22;79(25):1167-8.

引用本文的文献

1

Changes of circulating thyroid autoantibody levels during and after the therapy with methimazole in patients with Graves' disease.格雷夫斯病患者在服用甲巯咪唑治疗期间及治疗后的循环甲状腺自身抗体水平变化

J Endocrinol Invest. 1982 Jan-Feb;5(1):13-9. doi: 10.1007/BF03350476.

2

The value of IgG separation for the detection of LATS in human serum.IgG分离在检测人血清中长效甲状腺刺激素（LATS）方面的价值。

Clin Exp Immunol. 1969 May;4(5):597-601.

3

Effects of long-acting thyroid stimulator on thyrotropin stimulation of adenyl cyclase activity in thyroid plasma membranes.长效甲状腺刺激素对促甲状腺素刺激甲状腺质膜腺苷酸环化酶活性的影响。

J Clin Invest. 1972 Mar;51(3):463-72. doi: 10.1172/JCI106834.